Xiaoling Wang | Rice | Best Researcher Award

Posted on by Pencis

Prof. Xiaoling Wang | Rice | Best Researcher Award

Jiangxi Academy of Agricultural Sciences | China

🌟 WANG XIAOLING: A PIONEER IN RICE GENETICS AND BREEDING

🎓 EARLY ACADEMIC PURSUITS

Wang Xiaoling embarked on his academic journey in biotechnology at the College of Agriculture, South China University of Tropical Agriculture, earning his bachelor's degree in 2005. He further specialized in crop genetics and breeding during his master's studies at Hainan University (2005-2008). His commitment to agricultural research led him to pursue a Ph.D. in crop genetics and breeding at the College of Agriculture, South China Agricultural University, from 2013 to 2017.

💼 PROFESSIONAL ENDEAVORS

Since 2008, Wang Xiaoling has been a part of the Rice Research Institute at Jiangxi Academy of Agricultural Sciences. He progressed from a research intern to an assistant researcher and is now an associate researcher. His professional journey also includes a secondment at the Jiangxi Province Office of the Leading Group for Modern Seed Industry Development (Agriculture and Rural Department of Seed Industry Special Class) from 2021 to 2022.

🌱 CONTRIBUTIONS AND RESEARCH FOCUS ON RICE

Wang Xiaoling is primarily engaged in the research on hybrid advantages of indica and japonica rice. His research focuses on gene cloning of major quantitative trait loci (QTL) for rice panicle length and their application in molecular breeding. His contributions extend to the development of high-yielding japonica-indica hybrid rice varieties, improving agricultural productivity and food security.

📚 RESEARCH PROJECTS

Wang Xiaoling has led and participated in several significant research projects, including:

  • National Natural Science Foundation of China (2021-2024): Gene cloning of major QTL for rice panicle length and its application in molecular breeding.
  • Jiangxi Youth Science Fund Project (2019-2021): Gene cloning and genetic effect analysis of the major QTL-qPL6 for rice panicle length.
  • Basic Research and Talent Training Project of Jiangxi Academy of Agricultural Sciences (2023-2025): Creation of Japonica-Indica Rice Materials and Research on Yield Gene Mining and Mechanism.
  • Jiangxi Natural Science Foundation Key Project (2023-2026): Creation and Genetic Mechanism Study of High-yield Japonica-Indica Multi-grain Rice.
  • Jiangxi Academy of Agricultural Sciences Innovation Fund Doctoral Start-up Project (2018-2021).

🌟 IMPACT AND INFLUENCE

Wang Xiaoling has made remarkable contributions to rice breeding, enhancing genetic diversity and improving crop yield. His work has been instrumental in advancing molecular breeding techniques for rice. By leveraging hybrid vigor, his research supports the agricultural sector in producing more resilient and high-yielding rice varieties, significantly impacting food security and sustainable agriculture.

📝 ACADEMIC PUBLICATIONS AND CITATIONS

Wang Xiaoling has published over 20 research papers in esteemed journals, including Scientific Reports, Journal of Genetics and Genomics, and Plant Breeding. His research findings have contributed to the broader scientific community, influencing fellow researchers in the field of crop genetics.

🔒 PATENTS AND BOOKS

He has received three authorized invention patents related to rice breeding innovations and has co-edited and published a significant book in the field.

🏆 AWARDS AND HONORS

Wang Xiaoling's dedication to research and development has been recognized with several honors, including being named an "Outstanding Communist Party Member" in 2019 for his exemplary contributions.

🌾 LEGACY AND FUTURE CONTRIBUTIONS

Wang Xiaoling’s work has paved the way for the future of rice genetics and breeding. His research continues to bridge gaps in hybrid rice development, improving global agricultural sustainability. Moving forward, his contributions are expected to drive further advancements in crop genetics, aiding in climate resilience and higher-yield rice production for global food security.

📑 NOTABLE PUBLICATIONS 

"Characterization and application of the qPL6.2 in regulating panicle length of rice (Oryza sativa L.)" 

  • Authors: W., Fang, Weicong , X., Luo, Xin , S., Tang, Shusheng , C., Yu, Chuanyuan , X., Wang, Xiaoling
  • Journal: Discover Life
  • Year: 2024

Nida Imtiaz | Developmental Biology | Best Researcher Award

Posted on by Pencis

Dr. Nida Imtiaz | Developmental Biology | Best Researcher Award

Ningbo University | China

Author Profile

Scopus

Google Scholar

👩‍🎓 NIDA IMTIAZ: A DEDICATED RESEARCHER IN AQUACULTURE AND MARINE SCIENCES

🎓 EARLY ACADEMIC PURSUITS

Nida Imtiaz embarked on her academic journey with a strong foundation in biological sciences. She pursued her education in Pakistan, obtaining:

  • Ph.D. (Dec. 2024) in Aquaculture from Ningbo University, China.
  • M.Phil. in Animal Genomics and Biotechnology from the PARC Institute of Advanced Studies in Agriculture, National Agricultural Research Centre (NARC), Islamabad, Pakistan.
  • M.Sc. in Zoology from PMAS Arid Agriculture University, Rawalpindi, Pakistan.
  • B.Sc. from the University of the Punjab, Lahore, Pakistan.
  • Intermediate (Pre-Medical) and Matriculation from BISE, Rawalpindi, Pakistan.

🌍 PROFESSIONAL ENDEAVORS

Nida Imtiaz has accumulated extensive research and professional experience in the fields of aquaculture, fisheries, and biological sciences. Her significant contributions include:

  • Internship at a reputed feed mill (Aug 2013 - Nov 2014).
  • Research Assistant in Animal Nutrition Laboratories at NARC Islamabad (Jan 2016 - Feb 2017).
  • Assistant Scientific Officer in the Aquaculture and Fisheries Program at NARC Islamabad (April 2017 - June 2018).
  • Extensive research on crab culture and embryogenesis, particularly with Scylla paramamosain and Portunus trituberculatus.

📝 CONTRIBUTIONS AND RESEARCH FOCUS ON DEVELOPMENTAL BIOLOGY

Her research primarily focuses on aquaculture, marine sciences, and biological sciences, with an emphasis on:

  • Embryonic development in mud crabs (Scylla paramamosian), analyzing morphological, physiological, and molecular dynamics.
  • Impact of noise on stress response in Portunus trituberculatus in land-based monoculture systems.
  • Comparative analysis of amino acid and fatty acid profiles in different Scylla species to unveil their nutritional benefits.
  • Aflatoxin contamination in animal feed and milk in Pakistan.
  • Aqua feed production for commercially important fish species.
  • Study of Parkinson’s disease prevalence and fungal skin infestations in human populations.

💪 IMPACT AND INFLUENCE

Nida Imtiaz has made substantial contributions to aquaculture research, particularly in the areas of:

  • Crustacean embryology and nutritional analysis, influencing sustainable aquaculture practices.
  • Enhancing feed quality and safety in Pakistan’s livestock industry.
  • Promoting bioinformatics and statistical modeling in fisheries and marine sciences.
  • Contributing to scientific knowledge through international conferences, seminars, and research collaborations.

🎯 ACADEMIC CITATIONS AND PUBLICATIONS

Her research findings are currently under submission in reputed scientific journals:

  • "Comparative transcriptome profiles across distinct developmental stages in Scylla paramamosain embryos" (Comparative Biochemistry and Physiology Part-D, 2024).
  • "Mutation Analysis of tp53 in colorectal cancer, Peshawar, Khyber Pakhtunkhwa, Pakistan." (International Journal of Biosciences).

🏆 AWARDS AND RECOGNITIONS

Nida Imtiaz has received multiple prestigious awards, including:

  • Zhuo Chuang Scholarship (2023) at Ningbo University, Zhejiang, China.
  • Chinese Government Scholarship (2019-onwards) for her Ph.D. studies at Ningbo University.

📚 CONFERENCES AND SEMINARS

She has actively participated in academic discussions and knowledge-sharing platforms:

  • 4th International Conference on Biological and Computer Sciences at Capital University of Science and Technology, Islamabad.
  • National Policy Dialogue on Aflatoxin Contamination of Milk in Pakistan.
  • Mountain-Specific Innovative Solutions Conference (2017) at NARC, Islamabad.
  • 12th Chinese Symposium on Crustacean Aquaculture (2023) in Ningbo, China.

📝 FUTURE CONTRIBUTIONS AND LEGACY

As a dedicated scientist, Nida Imtiaz aims to:

  • Advance research in marine and aquaculture sciences, particularly in sustainable fisheries.
  • Develop innovative solutions for aqua feed production to enhance food security.
  • Contribute to bioinformatics and computational biology for better understanding of genetic mechanisms in marine species.
  • Mentor and train young researchers, fostering future experts in biological sciences.

📑NOTABLE PUBLICATIONS 

"Lipid dynamics during embryonic development of Scylla paramamosain: Insights from lipidomics" 

  • Authors: N., Imtiaz, Nida , Y., Jiang, Yaqi , Y., Yangfang, Ye , M., Changkao, Mu , Q., Wu, Qingyang
  • Journal: Aquaculture
  • Year: 2025

Esther MORALEDA SEPULVEDA | Disability | Excellence in Research

Posted on by Pencis

Prof. Dr. Esther MORALEDA SEPULVEDA | Disability | Excellence in Research

Complutense University of Madrid | Spanish

Author Profile

Scopus

Orcid ID

Google Scholar

✨ DR. ESTHER MORALEDA SEPÚLVEDA: A LEADER IN PSYCHOLOGY AND SPEECH THERAPY ✨

EARLY ACADEMIC PURSUITS 🎓

Dr. Esther Moraleda Sepúlveda began her academic journey with a Bachelor’s Degree in Psychology from the National University of Distance Education (UNED), where she specialized in both clinical and educational psychology. To further enhance her expertise, she pursued a Diploma in Speech Therapy at the University of Castilla-La Mancha. Her academic commitment continued with a Master’s Specialization in Psychology Research from UNED, laying the groundwork for her future research career.

Her doctoral studies culminated in a Ph.D. from the University of Castilla-La Mancha, where she defended her thesis, “Morphosyntactic Profile and Speech Therapy Intervention in Children with Down Syndrome,” earning a unanimous Cum Laude distinction. This solid academic foundation set the stage for her future contributions to psychology and speech therapy.

PROFESSIONAL ENDEAVORS 🌟

Dr. Moraleda Sepúlveda has been accredited by ANECA as both a Contracted Doctor and a Professor at a Private University, as well as a tenured university professor. Her professional career spans multiple academic institutions, including:

  • Camilo Jose Cela University
  • European University
  • University of Castilla-La Mancha (where she currently serves as an Assistant Professor)
  • Complutense University of Madrid

She has taught a range of subjects at the undergraduate, graduate, postgraduate, and master’s levels, providing students with in-depth knowledge in her areas of specialization. In addition, she has supervised numerous final degree projects, contributing to the next generation of scholars.

Beyond academia, Dr. Moraleda Sepúlveda has extensive professional experience in clinical and educational psychology, having worked as a psychologist and speech therapist in various clinics, hospitals, and associations. This hands-on experience has greatly enriched her teaching and research.

CONTRIBUTIONS AND RESEARCH FOCUS ON  DISABILITY🔬

Dr. Moraleda Sepúlveda’s research interests primarily focus on:

  • Language development and speech therapy interventions
  • Morphosyntactic profiles in children with Down syndrome
  • Psychological and cognitive development

Her research output includes:

  • Publications in high-impact journals, including those indexed in Journal Citation Reports (Q1 and Q2).
  • Articles in specialized journals listed in DICE, Latindex, and IN-RECs.
  • More than 60 presentations at national and international conferences.
  • Participation in multiple research projects, including three as a principal investigator and several as a collaborating researcher in national-level projects.
  • Recipient of the 8th Down Syndrome Research Award (2015) from the Down Madrid Foundation, recognizing her outstanding contributions to the field.

IMPACT AND INFLUENCE 📈

Dr. Moraleda Sepúlveda’s work has had a significant impact on both the academic and clinical fields. Through her research, she has:

  • Advanced understanding of language development in children with Down syndrome.
  • Influenced speech therapy techniques and interventions.
  • Contributed to educational psychology methodologies.
  • Provided clinical insights that have been integrated into therapy programs across various institutions.

Her international conference contributions have facilitated collaborations, further enhancing the global reach of her research.

ACADEMIC CITATIONS AND RECOGNITIONS 🌟

Dr. Moraleda Sepúlveda’s academic impact is reflected in her:

  • Total number of research six-year positions granted
  • Number of doctoral theses supervised in the last 10 years
  • Total citations of her published work
  • Average citations per year over the last five years
  • Publications in Q1 journals
  • H-index, demonstrating the long-term influence of her research

These indicators position her as a leading scholar in psychology and speech therapy.

LEGACY AND FUTURE CONTRIBUTIONS 🎯

Dr. Moraleda Sepúlveda’s contributions to academia and clinical practice continue to shape the future of psychology and speech therapy. Moving forward, she aims to:

  • Expand her research on cognitive and language development in individuals with developmental disorders.
  • Develop innovative speech therapy methodologies to enhance communication skills in children with special needs.
  • Strengthen international collaborations to advance research in the field.
  • Mentor young researchers to ensure the continuation of high-quality research in psychology and speech therapy.

Her work stands as a testament to her dedication to scientific advancement, education, and clinical excellence.

NOTABLE PUBLICATIONS 📑

"Transposition and substitution-letter effects in a flanker task: Evidence from children and adults" 

  • Authors: M.L.V., Lázaro, Miguel López Villasenor , L., García, Lorena , A., Martínez, Alfonso , E., Moraleda, Esther
  • Journal: Quarterly Journal of Experimental Psychology
  • Year: 2024

"Evaluating Quality of Life in Families With Williams Syndrome Patients" 

  • Authors: ESTHER MORALEDA; Mario Arana; Patricia López
  • Journal: Preprint
  • Year: 2020

"Language Development Disorder in Fetal Alcohol Spectrum Disorders (FASD), a Case Study" 

  • Authors: Yuri E. Vega-Rodríguez; Elena Garayzabal-Heinze; Esther Moraleda-Sepúlveda
  • Journal: Languages
  • Year: 2020

"Morphological Difficulties in People with Developmental Language Disorder" 

  • Authors: Esther Moraleda-Sepúlveda; Patricia López-Resa
  • Journal: Children
  • Year: 2022

"Language Intervention in Down Syndrome: A Systematic Literature Review" 

  • Authors: Esther Moraleda-Sepúlveda; Patricia López-Resa; Noelia Pulido-García; Soraya Delgado-Matute; Natalia Simón-Medina
  • Journal: International Journal of Environmental Research and Public Health
  • Year: 2022

Minjuan Wang | Phenotype | Best Researcher Award

Posted on by Pencis

Assoc. Prof. Dr. Minjuan Wang | Phenotype | Best Researcher Award

China Agricultural University | China

Author Profile

Scopus

Google Scholar

🌱 MINJUAN WANG: PIONEER IN INTELLIGENT AGRICULTURE 🌾

EARLY ACADEMIC PURSUITS 🎓

Minjuan Wang’s academic journey reflects her deep-rooted commitment to advancing agricultural and biological sciences. She earned her Bachelor of Science degree in Bioengineering from Hunan Agricultural University in 2008. She then pursued a Master’s degree in Crop Genetics and Breeding at Jilin University, under the supervision of Prof. Han Tianfu, further honing her expertise in plant science. Her pursuit of knowledge led her to Beihang University, where she obtained a Ph.D. in Biomedical Engineering in 2017 under the guidance of Prof. Liu Hong. To expand her research scope internationally, she worked as a Visiting Scholar at the University of Guelph’s Ontario Agriculture College in Canada (2015-2017), collaborating with Prof. Michael Dixon in Environmental Science.

PROFESSIONAL ENDEAVORS 👩‍🔬

Currently, Minjuan Wang serves as an Associate Professor at China Agricultural University, specializing in Intelligent Agriculture. Her research focuses on integrating cutting-edge technology with agricultural practices to enhance efficiency and productivity. Over the past five years, she has led 10 provincial-level funded projects and played a key role in over 10 national and provincial research initiatives. Her work spans a multidisciplinary domain, combining computer vision, deep learning, and environmental monitoring to revolutionize modern agriculture.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHENOTYPE🔬

Minjuan Wang’s research integrates artificial intelligence (AI), computer vision, and environmental sensing to innovate next-generation smart agricultural systems. Her primary research fields include:

  • 2D/3D Image Processing of Plants: Developing AI-based computational methods for plant analysis.
  • Intelligent Extraction Algorithms for Crop Phenotypic Data: Employing deep learning and model coupling techniques to analyze multi-source data.
  • Digital Monitoring Technologies for Plants and Animals: Enhancing agricultural efficiency through real-time data collection.
  • Interdisciplinary Research on Phenotypes, Genes, and Environment: Facilitating precision breeding and sustainable agricultural practices.

Her innovations aim to address global challenges in food security by improving high-quality food production while mitigating the effects of climate change and population growth.

IMPACT AND INFLUENCE 🌍

Minjuan Wang’s contributions have significantly shaped the future of precision agriculture and smart farming technologies. Her interdisciplinary research has helped bridge the gap between agriculture, artificial intelligence, and environmental sciences. By pioneering advanced phenotypic sensing and monitoring technologies, she has contributed to improving crop yields, disease resistance, and sustainability.

ACADEMIC CITATIONS 📚

Her work has been widely recognized, with numerous publications in high-impact journals and extensive citations in the fields of agricultural technology, artificial intelligence in farming, and plant science. Her research findings are frequently referenced by scholars and professionals working in computer vision for agriculture, environmental monitoring, and digital farming systems.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

Minjuan Wang’s legacy is deeply rooted in revolutionizing modern agriculture through AI-driven advancements. Her ongoing work in phenotypic data analysis and intelligent monitoring is paving the way for next-generation precision farming. In the future, she aims to expand her research into global agricultural sustainability, AI-driven crop improvement, and smart farm automation to ensure a more resilient food production system.

By merging technology and agriculture, Minjuan Wang continues to be a driving force in intelligent farming—an inspiration for the next generation of researchers dedicated to agricultural innovation and sustainability.

NOTABLE PUBLICATIONS 📑

"High-throughput proximal ground crop phenotyping systems – A comprehensive review" 

  • Authors: Z., Rui, Zhaoyu , Z., Zhang, Zhao , M., Zhang, Man, M., Ghasemi-Varnamkhasti, Mahdi , R., Radi, Radi
  • Journal: Computers and Electronics in Agriculture
  • Year: 2024

"A Hyperspectral Deep Learning Model for Predicting Anthocyanin Content in Purple Leaf Lettuce" 

  • Authors: M., Zhang, Meiling , Y., Chen, Yongjie , M., Wang, Minjuan , M., Li, Minzan , L., Zheng, Lihua Guang Pu Xue Yu Guang Pu Fen Xi
  • Journal: Spectroscopy and Spectral Analysis
  • Year: 2024

"High-throughput soybean pods high-quality segmentation and seed-per-pod estimation for soybean plant breeding" 

  • Authors: S., Yang, Si , L., Zheng, Lihua , T., Wu, Tingting , M., Li, Minzan , M., Wang, Minjuan
  • Journal: Engineering Applications of Artificial Intelligence
  • Year: 2024

"Online learning method for predicting air environmental information used in agricultural robots" 

  • Authors: Y., Wang, Yueting , M., Li, Minzan , R., Ji, Ronghua , Y., Zhang, Yao , L., Zheng, Lihua
  • Journal: International Journal of Agricultural and Biological Engineering
  • Year: 2024

"Extraction of the single-tiller rice phenotypic parameters based on YOLOv5m and CBAM-CPN" 

  • Authors: H., Chen, Huiying , Q., Song, Qingfeng , T., Chang, Tiangen , M., Zhang, Man , M., Wang, Minjuan Nongye Gongcheng Xuebao
  • Journal: Transactions of the Chinese Society of Agricultural Engineering
  • Year: 2024

Yong Xu | Cartilage Tissue | Best Researcher Award

Posted on by Pencis

Dr. Yong Xu | Cartilage Tissue | Best Researcher Award

Tongji University | China

Author Profile

Scopus

✨ XU YONG: A PIONEER IN TUMOR TREATMENT AND TISSUE REPAIR ✨

🎓 EARLY ACADEMIC PURSUITS

Xu Yong was born on May 29, 1991, in Fuzhou, Jiangxi, and pursued a career in medicine from an early age. He embarked on his academic journey at Tongji University School of Medicine, where he obtained his Bachelor of Clinical Medicine (2010-2015). With a keen interest in thoracic surgery and tissue engineering, he continued his education at Shanghai Pulmonary Hospital, earning a Master's Degree in Thoracic Surgery (2015-2018). His academic dedication led him to pursue a Ph.D. in Thoracic Surgery (2018-2021) at the same institution, where he developed expertise in tumor treatment and tissue repair.

🌟 PROFESSIONAL ENDEAVORS

Following his Ph.D., Xu Yong joined Shanghai Pulmonary Hospital as a Resident Physician (2021-2024), where he honed his clinical skills in thoracic surgery and tissue engineering. In August 2024, he transitioned to a research-focused role as a Special Associate Researcher at the Nuclear Industry 416 Hospital, Provincial Clinical Medical Research Center. His work in this position is instrumental in advancing innovative solutions for tracheal tissue engineering and regenerative medicine.

⚖️ CONTRIBUTIONS AND RESEARCH FOCUS ON CARTILAGE TISSUE

Xu Yong’s research primarily revolves around tissue engineering for cartilage regeneration, with a strong emphasis on functional tracheal reconstruction. His groundbreaking work introduced the "ring strategy", which enables the construction of bionic tracheal tissue with an alternating cartilage ring-connective tissue ring arrangement. This strategy successfully demonstrated long-term functional reconstruction of long-segment tracheal defects in rabbit models.

⚛️ MAJOR RESEARCH PROJECTS

Xu Yong has been the Principal Investigator (PI) in multiple prestigious projects, including:

  • Shanghai Science and Technology Rising Star Project (2024-2027): Focused on high-bionic tracheal tissue engineering (400,000 RMB).
  • Youth Talent Support Project (2023-2025): Dedicated to tracheal tissue engineering (300,000 RMB).
  • National Natural Science Foundation of China (2024-2026): Developing simulated tracheal tissue for large animal models (300,000 RMB).
  • Shanghai Natural Science Foundation (2022-2025): Advancing the construction of bioengineered trachea (200,000 RMB).

Additionally, he is a key participant in a major project funded by the National Natural Science Foundation of China (2,150,000 RMB), focusing on the precise matching of multiple cell types for bionic construction of long-segment trachea.

✨ IMPACT AND INFLUENCE

Xu Yong’s contributions have significantly influenced the field of tissue engineering and regenerative medicine, particularly in tracheal defect repair. His innovative biomimetic tracheal tissue construction has paved the way for improved clinical applications in treating long-segment tracheal defects. His research bridges the gap between basic science and clinical translation, offering promising therapeutic solutions for thoracic surgery.

🏆 ACADEMIC CITATIONS AND PUBLICATIONS

Xu Yong has an impressive publication record, contributing to over 30 SCI papers with a cumulative impact factor exceeding 300. His key achievements include:

  • 20 papers as first/co-first author
  • 14 papers as corresponding/co-corresponding author
  • 15 papers with an impact factor greater than 10
  • Highest single impact factor: 27.4

Notable journals where his research has been published:

  • Advanced Materials (ADV MATER)
  • Advanced Functional Materials (Adv. Funct. Mater.)
  • Advanced Science (Adv Sci.)
  • Composites Part B: Engineering (COMPOS PART B-ENG)
  • International Journal of Bioprinting (INT J BIOPRINTING)

Additionally, he holds over 10 patents related to tissue engineering and regenerative medicine.

🎬 LEGACY AND FUTURE CONTRIBUTIONS

Xu Yong’s pioneering efforts in tracheal tissue engineering and tumor treatment have established a new benchmark in the field. His ring strategy has set the foundation for future research in biomimetic tracheal reconstruction. Moving forward, he aims to:

  • Advance clinical translation of biomimetic tracheal tissue into human trials.
  • Explore novel biomaterials and tissue engineering scaffolds.
  • Collaborate on interdisciplinary projects integrating AI-driven biomaterial development.

His contributions will continue to shape the future of thoracic surgery, offering lifesaving solutions for patients with severe tracheal defects.

✨ CONCLUSION

Xu Yong is a trailblazer in regenerative medicine and thoracic surgery, whose dedication to tissue engineering and tracheal reconstruction has the potential to revolutionize the field. With a solid foundation in research, clinical expertise, and a vision for innovation, he is poised to make lasting contributions to modern medicine.

📑 NOTABLE PUBLICATIONS 

"Cartilage structure-inspired nanofiber-hydrogel composite with robust proliferation and stable chondral lineage-specific differentiation function to orchestrate cartilage regeneration for artificial tracheal construction" 

  • Authors: Y., Li, Yaqiang , X., Xun, Xiaowei , L., Duan, Liang , Y., Xu, Yong , H., Xia, Huitang
  • Journal: Bioactive Materials
  • Year: 2025

"Polydopamine-loaded microneedles for sequential tumor ablation and osteochondral regeneration" 

  • Authors: B., Lin, Bin , Y., Xu, Yong , B., Liang, Bing
  • Journal: Materials Letters
  • Year: 2025

"Copper hydrogen phosphate nanosheets functionalized hydrogel with tissue adhesive, antibacterial, and angiogenic capabilities for tracheal mucosal regeneration" 

  • Authors: P., Wang, Pengli , E., Gao, Erji , T., Wang, Tao , C., Yang, Chen , L., Duan, Liang
  • Journal: Journal of Nanobiotechnology
  • Year: 2024

"3D printing of Ceffe-infused scaffolds for tailored nipple-like cartilage development" 

  • Authors: J., Ding, Jinghao , C., Wei, Chuanzhi , Y., Xu, Yong , W., Dai, Wufei , R., Chen, Ru
  • Journal: BMC Biotechnology
  • Year: 2024

"Injectable and self-healing sulfated hyaluronic acid/gelatin hydrogel as dual drug delivery system for circumferential tracheal repair" 

  • Authors: Y., Yang, Yayan , X., Zhu, Xinsheng , X., Liu, Xuezhe , N., Song, Nan , Q., Feng, Qian
  • Journal: International Journal of Biological Macromolecules
  • Year: 2024

Junhua Wu | Tumor Gene Therapy | Excellence in Innovation

Posted on by Pencis

Prof Junhua Wu | Tumor Gene Therapy | Excellence in Innovation

Nanjing University | China

Author Profile

Scoups

Orcid ID

JUNHUA WU: PIONEERING RESEARCHER IN BIOMECHANICS AND ONCOLOGY 🔬

EARLY ACADEMIC PURSUITS 🎓

Junhua Wu embarked on his academic journey at Nanjing University (NJU), where he earned both his BSc in Life Sciences (1998–2002) and PhD in Life Sciences (2002–2007). His doctoral studies laid a strong foundation in molecular biology and biomechanics, equipping him with the expertise to make significant contributions to scientific research.

PROFESSIONAL ENDEAVORS 🏅

Following his graduation in June 2007, Junhua Wu remained at Nanjing University as a faculty member. His academic career has progressed steadily:

  • Lecturer (Since September 2007)
  • Associate Professor (Since December 2014)
  • Professor (Since December 2019)

He has received research funding from prestigious sources such as the National Natural Science Foundation of China, Key R&D Plan of Jiangsu Province, Natural Science Foundation of Jiangsu Province, and the Doctoral Program Fund of the Ministry of Education.

As an esteemed scholar, Professor Wu has published over 50 SCI papers in high-impact journals such as Nature Communications and holds 17 national invention patents. He has also contributed to academia through the compilation and translation of scientific monographs. His editorial roles include serving on the boards of Translational Oncology, Biocell, and Discovery Medicine.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR GENE THERAPY🔍

Professor Wu has made groundbreaking contributions in biomechanics, material science, and oncology. His research interests focus on protein hydrogels, tumorigenesis mechanisms, and novel cancer therapies.

1. Creation and Application of Hydrogels 💧

His work on protein hydrogels was a pioneering achievement in the field of biomechanics. He successfully demonstrated the ability to manipulate the mechanical properties of macromaterials by fine-tuning single protein molecules. His study, published in Nature Communications (2018), was a landmark contribution and has been cited 110 times.

His work was recognized in the 100th-anniversary special issue of international macromolecular science and was selected by the China Biomechanics Professional Committee as a key research advancement (2016–2018).

2. Mechanism of Tumorigenesis and Development 🧬

Professor Wu’s contributions to oncology include his exosome theory of sorafenib resistance in hepatocellular carcinoma, published in JECCR (2016). This study has been cited 113 times, influencing subsequent research on drug resistance in various cancers. His findings provided a new understanding of cancer cell communication and treatment resistance.

3. Innovative Cancer Therapies 💊

Professor Wu has developed novel strategies for cancer treatment, leading to over 20 invention patents and more than 30 high-impact SCI publications.

His research on mechanically stable peptide-graphene oxide hybrid hydrogels for drug delivery was highlighted as a Web of Science highly cited paper (Top 1% globally). This work demonstrated precise drug release mechanisms and was recognized for its potential to revolutionize targeted cancer therapy.

His “Trojan Horse” strategy for oncolytic virus delivery represents another major breakthrough. Published in JECCR (2019), this method involves using graphene nanoflakes to enhance viral delivery to tumors, significantly improving therapeutic outcomes.

IMPACT AND INFLUENCE 🌍

Professor Wu’s research has had a profound impact on multiple disciplines, including biomechanics, biomaterials, and oncology. His pioneering studies have inspired global researchers, with scholars from institutions such as the University of Wisconsin-Milwaukee drawing on his ideas for their work in Nature Communications, Science Advances, and PRL.

His cancer therapy innovations have been widely cited and applied by leading oncologists and material scientists. His findings have been positively reviewed and referenced in major scientific publications, solidifying his reputation as a thought leader in the field.

ACADEMIC CITATIONS 📑

Professor Wu’s work has received extensive recognition, accumulating hundreds of citations. Some notable statistics include:

  • 110+ citations for his 2018 Nature Communications paper on protein hydrogels.
  • 113+ citations for his 2016 JECCR paper on exosome-mediated drug resistance.
  • 122+ citations for his 2015 Nanoscale paper on peptide-graphene oxide hybrid hydrogels.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

Professor Junhua Wu’s legacy is defined by his interdisciplinary approach, bridging biomechanics, biomaterials, and cancer therapy. His innovative methodologies continue to shape biomedical engineering and oncology research.

Moving forward, he aims to:

  • Expand the applications of protein hydrogels for regenerative medicine and tissue engineering.
  • Advance tumor microecology studies to develop next-generation immunotherapies.
  • Refine oncolytic virus-based cancer treatments, enhancing their efficacy and clinical applications.

CONCLUSION 🏆

Junhua Wu stands as a pioneering figure in his fields of expertise. His work has redefined our understanding of mechanobiology and cancer treatment, earning him a place among the most influential scientists in modern biomedical research. His dedication to innovation ensures that his impact will continue to resonate for years to come.

NOTABLE PUBLICATIONS 📑

"SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy" 

  • Authors: P., Wang, Peng , J., Qiu, Jiannan , Y., Fang, Yuan , J., Wu, Junhua , C., Jiang,
  • Journal: Chunping Cell Death and Differentiation
  • Year: 2025

"Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy" 

  • Authors: K., Liu, Kua , L., Kong, Lingkai , H., Cui, Huawei , C., Jiang, Chunping , J., Wu, Junhua
  • Journal: Cell Reports Medicine
  • Year: 2024

"CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinoma" 

  • Authors: D., Ma, Ding , S., Liu, Shuwen , K., Liu, Kua , J., Wu, Junhua , C., Jiang, Chunping
  • Journal: Translational Oncology
  • Year: 2024

"Toward Practical Applications of Engineered Living Materials with Advanced Fabrication Techniques" 

  • Authors: C., Lu, Chenjing , Y., Huang, Yaying , J., Cui, Jian , Y., Cao, Yi , S., Yin, Sheng
  • Journal: ACS Synthetic Biology
  • Year: 2024

"Structurally and mechanically tuned macroporous hydrogels for scalable mesenchymal stem cell-extracellular matrix spheroid production " 

  • Authors: S., Yin, Sheng , H., Wu, Haipeng , Y., Huang, Yaying , W., Wang, Wei , Y., Cao, Yi
  • Journal: Proceedings of the National Academy of Sciences of the United States of America
  • Year: 2024

Ying Wang | Chromosomal Abnormalities | Best Researcher Award

Posted on by Pencis

Dr. Ying Wang | Chromosomal Abnormalities | Best Researcher Award 

Tongji medical college of huazhong university of science and technology | China

Author Profile

Scopus

【YING WANG: A DEDICATED HEMATOLOGY RESEARCHER】

🎓 EARLY ACADEMIC PURSUITS

Ying Wang’s passion for medicine began at a young age, inspiring her to pursue an extensive medical education. She completed eight years of rigorous training, which included five years of clinical medical study followed by three years specializing in hematology. During this time, she developed a strong interest in laboratory science and hematology technology. Her academic journey allowed her to master fundamental hematological knowledge and acquire essential experimental skills such as polymerase chain reaction (PCR), cell culture, and morphology. This foundation led her to continue her professional journey in the hematology laboratory upon graduation.

💼 PROFESSIONAL ENDEAVORS

Since 2008, Ying Wang has been working in the Hematology Laboratory of Tongji Hospital at Tongji Medical College, Huazhong University of Science and Technology. Her career began with a primary focus on cell morphology, which is the cornerstone of hematopathology. Over three years, she gained an in-depth understanding of the characteristics of different hematological testing methods, including morphology, immunology, cytogenetics, and molecular biology.

For the past seven years, her work has been centered on cytogenetics, particularly in chromosomal analysis and fluorescence in situ hybridization (FISH). Through dedicated training and hands-on practice, she has mastered G-banding chromosomal analysis and developed expertise in applying FISH techniques to malignant blood diseases.

Currently, she leads the Cytogenetics Group, overseeing four team members and ensuring the efficiency and accuracy of daily operations. Under her leadership, her team has successfully established cytogenetic analysis for blood diseases and has processed a significant volume of patient samples. Her contributions to the field are reflected in her authorship of two published research papers.

📝 CONTRIBUTIONS AND RESEARCH FOCUS ON CHROMOSOMAL ABNORMALITIES

Ying Wang’s research focuses on cytogenetic analysis in hematology, particularly in the chromosomal abnormalities associated with blood diseases. Her expertise in G-banding chromosomal analysis and FISH techniques has significantly enhanced diagnostic and prognostic capabilities in hematopathology. She has contributed extensively to the establishment and optimization of cytogenetic methodologies in her laboratory, leading to improved patient diagnoses and treatment strategies.

Despite the labor-intensive nature of cytogenetic analysis, she remains deeply passionate about her work. Knowing that her contributions provide crucial diagnostic and prognostic data to clinicians, she continues to dedicate herself to advancing the field of hematology.

🌟 IMPACT AND INFLUENCE

Ying Wang’s work has had a profound impact on the field of hematology, particularly in China. By pioneering cytogenetic analysis for blood diseases in her laboratory, she has played a critical role in improving diagnostic precision. Her leadership in the Cytogenetics Group has enabled her team to process a high volume of patient samples, ensuring timely and accurate results that guide treatment decisions.

Her research contributions have also influenced the broader scientific community through her publications. Additionally, her involvement as a member of the Hubei Medical Biology and Immunology Society demonstrates her commitment to professional collaboration and knowledge exchange within the field.

📊 ACADEMIC CITATIONS

Ying Wang has authored two peer-reviewed research papers focusing on cytogenetics and blood disease analysis. These publications have contributed to the scientific community’s understanding of chromosomal abnormalities in hematology. Her work continues to be cited by researchers working on similar topics, further solidifying her influence in the field.

💪 LEGACY AND FUTURE CONTRIBUTIONS

As she advances in her career, Ying Wang remains committed to furthering her expertise in hematology and cytogenetics. She acknowledges the limitations of her current knowledge and continuously seeks to expand her skills through further studies and international collaborations. She aspires to stay at the forefront of hematological advancements by engaging with leading laboratories worldwide.

Upon completing her further studies, she aims to implement cutting-edge techniques in her laboratory, thereby enhancing the quality and scope of cytogenetic analysis available to patients in China. Her long-term vision is to contribute to the continued evolution of hematology research and to provide even more precise and valuable diagnostic information for improved patient outcomes.

👨‍🎓 POSITIONS AND HONORS

  • 2008 – Present: Hematology Laboratory, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology (Specialized in Morphology and Cytogenetics).
  • 2017 – Present: Member, Hubei Medical Biology and Immunology Society, China.

📑NOTABLE PUBLICATIONS

"Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation" 

  • Authors: X., Kong, Xin , Z., Xu, Ziyi , Y., Wu, Yanjun , Y., Zhao, Ye , F., Chen, Feng
  • Journal: Journal of Hematology and Oncology
  • Year: 2024

" Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial " 

  • Authors: J., Lu, Jing , H., Qiu, Huiying , Y., Wang, Ying , Y., Zhu, Yu , S., Chen, Suning
  • Journal: Journal of Hematology and Oncology
  • Year: 2024

"CD19 CAR T-cell therapy in relapsed TCF3-HLF-positive B-cell acute lymphoblastic leukemia" 

  • Authors: Y., Yao, Yao , J., Zhou, Jin , Y., Li, Yanting , D.P., Wu, De Pei , Y., Wang, Ying
  • Journal: Annals of Hematology
  • Year: 2024

"Risk factors for in-hospital mortality in recipients of allogeneic hematopoietic stem cell transplantation with acute respiratory distress syndrome: a retrospective study based on the 2023 new definition of acute respiratory distress syndrome " 

  • Authors: S., Guo, Shiqi , D., Xie, Dan , Y., Gao, Ye , Y., Wang, Ying , Q., Guo, Qiang
  • Journal: BMC Pulmonary Medicine
  • Year: 2024

"A phase II study of belumosudil for chronic graft-versus-host disease in patients who failed at least one line of systemic therapy in China " 

  • Authors: Y., Wang, Ying , D.P., Wu, De Pei , X., Zhang, Xiang , Y., Wang, Yu , Y., Zhang, Ying
  • Journal: BMC Medicine
  • Year: 2024

Pinelopi Petropoulou | Diabetes | Best Researcher Award

Posted on by Pencis

Dr. Pinelopi Petropoulou | Diabetes | Best Researcher Award

University of West Attica | Greece

Author Profile

Scopus

Orcid ID

📚 DR. PINELOPI PETROPOULOU: A MULTIFACETED EXPERT IN DENTISTRY AND PUBLIC HEALTH

📖 EARLY ACADEMIC PURSUITS

Dr. Pinelopi Petropoulou was born and resides in Athens, Greece. She pursued her academic journey in Dentistry at the Kapodistrian University of Athens. Demonstrating a commitment to specialized knowledge, she furthered her education with post-graduate studies in Periodontology and Prosthodontics at the English-speaking Witten/Herdecke University in Germany. Additionally, she completed advanced training in Implantology at the German Academy of Practice and Science (APW).

Her dedication to multidisciplinary expertise led her to become certified as a Laser Safety Officer by Aachen University and to receive certification from Demokritos for operating a Radiological Laboratory in Athens. Moreover, she is currently a Ph.D. candidate (PhDc) in Oncology Care at the University of West Attica and has pursued postgraduate studies in Planning and Implementing Gender Equality Policies at the Pedagogical Department of the University of the Aegean.

💼 PROFESSIONAL ENDEAVORS

Dr. Petropoulou operates a private dental clinic in Athens, where she applies her extensive expertise in periodontology, prosthodontics, and implantology. Her clinical practice is distinguished by a patient-centered approach and the integration of advanced medical technologies.

In addition to her clinical work, Dr. Petropoulou serves as a reviewer for several prestigious scientific journals, including the International Journal of Science, Technology and Society, Cureus, and Social Work: Review of Social Sciences. Her academic contributions extend to her role as an Academic Board Member for Global Open Share Publishing.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DIABETES

Dr. Petropoulou's research interests are diverse, encompassing oncology care, public health, and advanced dental practices. She specializes in the treatment of oncological patients and has a particular focus on "Global Public Health and Environment." Her participation in numerous scientific conferences and her publications in peer-reviewed journals reflect her commitment to advancing knowledge in these fields.

Her work bridges the gap between dental health and broader public health concerns, contributing valuable insights into patient care and community health initiatives.

🌍 IMPACT AND INFLUENCE

Dr. Petropoulou's influence extends beyond her clinical and academic work into social advocacy and public service. As a member of Doctors of the World, she volunteered for the 2014-2015 primary schools dental problems registration and prevention campaign, earning recognition for her contributions.

She holds leadership roles in several prominent organizations, including:

  • Vice-President of the Women's Union of Greece (EGE) in Athens
  • International Relations Advisor for the Association of Greek Women Scientists (SEE)
  • Secretary of the Communication and Interconnection Department of the Hellenic Solid Waste Management Association (EEDSA)
  • Member of Women for Oncology Hellas
  • Member of the Amnesty International Board in Greece

Her active engagement in these organizations underscores her commitment to social responsibility, gender equality, and environmental sustainability.

📊 ACADEMIC CITATIONS

Dr. Petropoulou's scholarly work is recognized through her contributions to scientific literature and peer-reviewed journals. Her role as a reviewer further emphasizes her expertise and dedication to maintaining high academic standards. Her multidisciplinary research has informed best practices in both dentistry and public health.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Pinelopi Petropoulou's legacy lies in her integrative approach to dental medicine, oncology care, and public health advocacy. Her work exemplifies a commitment to interdisciplinary collaboration and the translation of research into meaningful societal impact.

Looking ahead, she aims to continue advancing oncology care, promoting gender equality in healthcare policy, and expanding her research in global public health. Through her clinical excellence, academic contributions, and social activism, Dr. Petropoulou continues to shape the future of healthcare and public welfare.

🌟 OTHER NOTABLE ACHIEVEMENTS

  • Multilingual: Fluent in English and French
  • Certified Laser Safety Officer and Radiological Laboratory Operator
  • Recognized volunteer service with Doctors of the World

Dr. Pinelopi Petropoulou's career is a testament to the power of combining clinical expertise, academic rigor, and social commitment to effect positive change on both local and global scales.

NOTABLE PUBLICATIONS📑

"Research of the air pollution connection with the presence and evοlution of chronic diseases" 

  • Authors: P., Petropoulou, Pinelopi , I., Kalemikerakis, Ioannis , O., Govina, Ourania
  • Journal: Archives of Hellenic Medicine
  • Year: 2025

Kang Yang | Metabolic Disorders | Best Researcher Award

Posted on by Pencis

Dr. Kang Yang | Metabolic Disorders | Best Researcher Award

Northern Jiangsu People's Hospital affiliated with Yangzhou University | China

Author Profile

Scopus

Orcid Id

EARLY ACADEMIC PURSUITS 🎓

Kang Yang embarked on his academic journey at Shandong First Medical University, where he pursued a Bachelor of Medicine (BM) in 2017 under the mentorship of Professor Jianhong Qi. His early interest in sports medicine and rehabilitation laid a strong foundation for his future contributions in the field.

Building on this, he further honed his expertise at Yangzhou University, obtaining a Master of Medicine (MM) in 2020 under the guidance of Professor Xianghe Chen. His postgraduate studies deepened his understanding of rehabilitation techniques, patient care, and innovative treatments in sports medicine.

PROFESSIONAL ENDEAVORS 💼

As a rehabilitation physician and therapist, Kang Yang is committed to enhancing the quality of life for patients recovering from injuries, surgeries, and physical impairments. His work integrates advanced rehabilitation methodologies with patient-centered approaches to ensure effective recovery and functional restoration.

Throughout his career, he has actively contributed to both clinical practice and academic research, focusing on rehabilitation strategies tailored for athletes and individuals with musculoskeletal disorders.

CONTRIBUTIONS AND RESEARCH FOCUS ON METABOLIC DISORDERS🔬

Kang Yang’s research primarily revolves around sports medicine and rehabilitation medicine. His investigations explore:

  • Innovative rehabilitation techniques for sports-related injuries.
  • Physiological and biomechanical adaptations in long-distance runners and athletes.
  • Post-injury recovery protocols aimed at optimizing healing and preventing re-injury.

His dedication to research has led to significant advancements in sports rehabilitation, with a particular focus on marathon runners and endurance athletes.

IMPACT AND INFLUENCE 🔍

Kang Yang's contributions extend beyond clinical settings. His work has influenced:

  • Rehabilitation strategies for sports professionals.
  • Medical education, through his involvement in teaching and mentoring young medical students.
  • Public awareness on the importance of injury prevention and rehabilitation in sports.

His clinical expertise and research have helped shape modern rehabilitation protocols, making a positive impact on both patient outcomes and medical practices.

ACADEMIC CITATIONS AND RECOGNITION 🏆

Kang Yang’s academic excellence has been recognized through multiple prestigious awards:

  • Special Prize (2018) & First Prize (2019) at the Jiangsu Sports Graduate Innovation Forum.
  • 2019 National Scholarship for Postgraduates (China).
  • First-class academic scholarship from Yangzhou University.

These accolades highlight his commitment to academic excellence, research innovation, and contributions to the medical community.

LEGACY AND FUTURE CONTRIBUTIONS🏰

Looking ahead, Kang Yang aims to:

  • Expand his research on sports rehabilitation and injury prevention.
  • Develop advanced therapeutic protocols for athletes and individuals recovering from physical trauma.
  • Collaborate with international experts to enhance rehabilitation medicine globally.
  • Continue mentoring students and young professionals in the field of rehabilitation sciences.

His unwavering passion and dedication position him as a future leader in the evolving landscape of sports medicine and rehabilitation.

BEYOND MEDICINE: PERSONAL INTERESTS 📚

Outside of his professional life, Kang Yang enjoys:

  • Long-distance running and marathons, reflecting his deep understanding of sports medicine from both a theoretical and practical perspective.
  • Reading, staying updated with the latest medical advancements and broadening his intellectual horizons.

NOTABLE PUBLICATIONS📑

"Exercise alleviates renal interstitial fibrosis by ameliorating the Sirt1-mediated TGF-β1/Smad3 pathway in T2DM mice" 

  • Authors: X., Chen, Xianghe , X., Zeng, Xinyu , X., Qiu, Xiao , X., Zhou, Xiangxiang , K., Yang, Kang
  • Journal: Endocrine Connections
  • Year: 2024

Chaohua Deng | Osteoarthritis | Best Researcher Award

Posted on by Pencis

Dr. Chaohua Deng | Osteoarthritis | Best Researcher Award

Huazhong University of Science and Technology | China

Author Profile

Scopus

👨‍⚕️ BIOGRAPHY OF CHAOHUA DENG

🏛 EARLY ACADEMIC PURSUITS

Chaohua Deng was born on April 12, 1988. He embarked on his academic journey in clinical medicine at Wuhan University, where he earned his Bachelor's degree in Clinical Medicine in 2011. Demonstrating a keen interest in advancing his expertise, he pursued a Master’s degree in Clinical Medicine at Wuhan University, completing it in 2013. Seeking further specialization, he continued his studies abroad and obtained a Ph.D. in Life and Health Sciences from the University of Lorraine, France, in 2017. His doctoral research contributed significantly to his understanding of ophthalmology and related biomedical sciences.

👨‍⚕️ PROFESSIONAL ENDEAVORS

Deng’s professional career has been dedicated to clinical ophthalmology, with progressive advancements in his roles at Tongji Hospital, Huazhong University of Science and Technology:

  • Physician (2017-2019): Started as a physician in the Department of Ophthalmology, where he gained hands-on experience in diagnosing and treating ophthalmic conditions.
  • Attending Physician (2019-Present): Promoted to Attending Physician, Deng played a more active role in patient care, surgical interventions, and medical research.
  • Associate Chief Physician (2022-Present): Achieved a senior position where he leads research projects and continues to contribute to clinical advancements in ophthalmology.

🏥 CONTRIBUTIONS AND RESEARCH FOCUS ON OSTEOARTHRITIS

Deng's research primarily focuses on the molecular mechanisms underlying eye diseases and innovative treatment approaches. His National Natural Science Foundation of China (NSFC) projects reflect his commitment to advancing ophthalmic science:

  • Irisin Activation in Trabecular Cells (Ongoing, Participant, 2023-2026): Investigating the Integrin αVβ5-Rac1 signaling pathway in trabecular meshwork cells to enhance aqueous outflow, a crucial area for glaucoma treatment.
  • Vitamin K and Trabecular Meshwork Aqueous Outflow (Completed, Principal Investigator, 2022-2024): Explored how Vitamin K upregulates MGP expression in trabecular cells, which can improve fluid dynamics in the eye.
  • Single-Cell Transcriptome Analysis on Retinal Injury (Completed, Participant, 2021-2024): Studied the role of Sideroflexin3 in retinal recovery through single-cell transcriptomics.

🌍 IMPACT AND INFLUENCE

Deng has made valuable contributions to the ophthalmology community through his clinical expertise and research. His findings have potential implications for glaucoma treatment, retinal injury recovery, and overall eye health. His involvement in international academic conferences has allowed him to share insights and collaborate with global experts.

📚 ACADEMIC CITES AND AWARDS

  • Patent Contribution (2018): Co-author of a patent on mineralocorticoid receptor antagonists for osteoarthritis treatment (WIPO PCT/EP2017/068785).
  • International Conference Participation (2016-2017): Attended the OARSI World Congress on Osteoarthritis in Amsterdam, Netherlands, presenting his work to an esteemed audience of researchers.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Chaohua Deng’s legacy is built upon his clinical excellence, research innovations, and contributions to ophthalmology. As an Associate Chief Physician, he is well-positioned to mentor young professionals, drive future research in ocular disease mechanisms, and pioneer new treatment modalities for eye conditions. His work continues to influence the field, with ongoing research that aims to enhance vision care and therapeutic strategies for ophthalmic diseases.

📑 NOTABLE PUBLICATIONS

"Irisin attenuates acute glaucoma-induced neuroinflammation by activating microglia-integrin αVβ5/AMPK and promoting autophagy " 

  • Authors: Q., Zhang, Qiuxiang , S., Xiang, Sifei , X., Chen, Xi , C., Deng, Chaohua , J., Wang, Junming
  • Journal: International Immunopharmacology
  • Year: 2024

"Beneficial Impact of Eicosapentaenoic Acid on the Adverse Effects Induced by Palmitate and Hyperglycemia on Healthy Rat Chondrocyte " 

  • Authors: C., Deng, Chaohua , N., Presle, Nathalie , A., Pizard, Anne , A., Bianchi, Arnaud , H., Kempf, Hervé
  • Journal: International Journal of Molecular Sciences
  • Year: 2024